Zobrazeno 1 - 10
of 94
pro vyhledávání: '"Yvonne Kahlert"'
Autor:
Alina Meeser, Christoph Bartenhagen, Lisa Werr, Anna-Maria Hellmann, Yvonne Kahlert, Nadine Hemstedt, Peter Nürnberg, Janine Altmüller, Sandra Ackermann, Barbara Hero, Thorsten Simon, Martin Peifer, Matthias Fischer, Carolina Rosswog
Publikováno v:
Cell & Bioscience, Vol 12, Iss 1, Pp 1-16 (2022)
Abstract Background Telomere maintenance mechanisms (TMM) are a hallmark of high-risk neuroblastoma, and are conferred by activation of telomerase or alternative lengthening of telomeres (ALT). However, detection of TMM is not yet part of the clinica
Externí odkaz:
https://doaj.org/article/04d7590f1e6a4f35ba877b94d65b186b
Autor:
Casper H.A. vanLeeuwen, Ralph J.M. Temmink, Hui Jin, Yvonne Kahlert, Bjorn J.M. Robroek, Matty P. Berg, Leon P.M. Lamers, Marloes vanden Akker, Roel Posthoorn, Annemiek Boosten, Han Olff, Elisabeth S. Bakker
Publikováno v:
Ecological Solutions and Evidence, Vol 2, Iss 3, Pp n/a-n/a (2021)
Abstract Ecosystems are increasingly managed to provide multiple benefits to humans, which often degrades their ecological integrity. This strongly applies to aquatic ecosystems, in which engineering can enhance flood protection, drinking water suppl
Externí odkaz:
https://doaj.org/article/67333a9180ad49618b199707499f896e
Autor:
Carolina Rosswog, Rene Schmidt, André Oberthuer, Dilafruz Juraeva, Benedikt Brors, Anne Engesser, Yvonne Kahlert, Ruth Volland, Christoph Bartenhagen, Thorsten Simon, Frank Berthold, Barbara Hero, Andreas Faldum, Matthias Fischer
Publikováno v:
Neoplasia: An International Journal for Oncology Research, Vol 19, Iss 12, Pp 982-990 (2017)
BACKGROUND: Current risk stratification systems for neuroblastoma patients consider clinical, histopathological, and genetic variables, and additional prognostic markers have been proposed in recent years. We here sought to select highly informative
Externí odkaz:
https://doaj.org/article/c6f0641f7ed243fea6fcc8ab5e4a9724
Autor:
Janina Fischer-Mertens, Felix Otte, Andrea Roderwieser, Carolina Rosswog, Yvonne Kahlert, Lisa Werr, Anna-Maria Hellmann, Maya Berding, Bill Chiu, Christoph Bartenhagen, Matthias Fischer
Publikováno v:
Cellular Oncology. 45:991-1003
Background The majority of high-risk neuroblastomas harbor telomerase activity, and telomerase-interacting compounds, such as 6-thio-2’-deoxyguanosine (6-thio-dG), have been found to impair the growth of telomerase-positive neuroblastoma cell lines
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::988dca94f08753aa1c5dbfcdfdc9107e
https://doi.org/10.1007/s13402-022-00702-8
https://doi.org/10.1007/s13402-022-00702-8
Autor:
Matthias Fischer, Benedikt Brors, Frank Westermann, Frank Berthold, Jessica Theissen, Thorsten Simon, Roland Eils, Manfred Schwab, Chunxuan Shao, Monika Ortmann, Richard G. Grundy, Isaac Yaniv, Smadar Avigad, Alexander Valent, Jean Bénard, Marta Piqueras, Rosa Noguera, Frank Speleman, Jo Vandesompele, Gudrun Schleiermacher, Olivier Delattre, Isabelle Janoueix-Lerosey, Gian Paolo Tonini, Paola Scaruffi, Akira Nakagawara, Miki Ohira, Robert Seeger, Shahab Asgharzadeh, Anne Engesser, Yvonne Kahlert, Andreas Faldum, Rene Schmidt, Carolina Sterz, Ruth Volland, Barbara Hero, Dilafruz Juraeva, André Oberthuer
Supplementary Data 1. This supplementary data comprises a step-by-step description on how our gene-expression based classification models were generated and validated
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::775a6802982592c68b0660667a5e03e7
https://doi.org/10.1158/1078-0432.22455450.v1
https://doi.org/10.1158/1078-0432.22455450.v1
Autor:
Matthias Fischer, Alexander Schramm, Barbara Hero, Benedikt Brors, Angelika Eggert, Frank Berthold, Frank Speleman, Jo Vandesompele, Frank Westermann, Jessica Theissen, Kristian Pajtler, Yvonne Kahlert, Sandra Ackermann, André Oberthür, Katleen DePreter, Bent Brockmeyer, Hagen S. Bachmann, Johannes H. Schulte
XLS file - 1949K
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::054d5180c3a7ac56f1c206effcd91776
https://doi.org/10.1158/1078-0432.22443806
https://doi.org/10.1158/1078-0432.22443806
Autor:
Matthias Fischer, Roland Eils, Benedikt Brors, Frank Berthold, Frank Westermann, Barbara Hero, Yvonne Kahlert, Lars Kaderali, André Oberthuer
Supplementary Data from Subclassification and Individual Survival Time Prediction from Gene Expression Data of Neuroblastoma Patients by Using CASPAR
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::851fba4828ac5f61cbe2d950befc3cff
https://doi.org/10.1158/1078-0432.22439595.v1
https://doi.org/10.1158/1078-0432.22439595.v1
Autor:
Frank Berthold, Barbara Hero, Karen Ernestus, Patrick Warnat, Harald Voth, Matthias Skowron, Yvonne Kahlert, Benedikt Brors, André Oberthuer, Matthias Fischer
Supplementary Table 2 from Differential Expression of Neuronal Genes Defines Subtypes of Disseminated Neuroblastoma with Favorable and Unfavorable Outcome
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4056f24db2cadf5206d2bce82e590f5f
https://doi.org/10.1158/1078-0432.22441648.v1
https://doi.org/10.1158/1078-0432.22441648.v1
Autor:
Matthias Fischer, Alexander Schramm, Barbara Hero, Benedikt Brors, Angelika Eggert, Frank Berthold, Frank Speleman, Jo Vandesompele, Frank Westermann, Jessica Theissen, Kristian Pajtler, Yvonne Kahlert, Sandra Ackermann, André Oberthür, Katleen DePreter, Bent Brockmeyer, Hagen S. Bachmann, Johannes H. Schulte
XLS file - 61K
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::15045866a1d2f2025fcf7b9d88d659d4
https://doi.org/10.1158/1078-0432.22443788.v1
https://doi.org/10.1158/1078-0432.22443788.v1
Autor:
Matthias Fischer, Benedikt Brors, Frank Westermann, Frank Berthold, Jessica Theissen, Thorsten Simon, Roland Eils, Manfred Schwab, Chunxuan Shao, Monika Ortmann, Richard G. Grundy, Isaac Yaniv, Smadar Avigad, Alexander Valent, Jean Bénard, Marta Piqueras, Rosa Noguera, Frank Speleman, Jo Vandesompele, Gudrun Schleiermacher, Olivier Delattre, Isabelle Janoueix-Lerosey, Gian Paolo Tonini, Paola Scaruffi, Akira Nakagawara, Miki Ohira, Robert Seeger, Shahab Asgharzadeh, Anne Engesser, Yvonne Kahlert, Andreas Faldum, Rene Schmidt, Carolina Sterz, Ruth Volland, Barbara Hero, Dilafruz Juraeva, André Oberthuer
Supplementary Figure 1. Highlights the EFS and OS for the cohort of neuroblastoma patients with MYCN-amplified disease (n=114, Fig 1a) and for th subcohort of patients >18 months of age with stage 4, MYCN non-amplified disease (n=102, fig. 1b). F, fa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c228f0350bfef9c250b0ac38eb3771c9
https://doi.org/10.1158/1078-0432.22455444
https://doi.org/10.1158/1078-0432.22455444